Comparing blood collection methods for a liver test
Part of Digestive system clinical trials.
This study is testing different ways to collect blood samples for a liver function test called HepQuant DuO. The test measures how well your liver processes a special substance, which may help doctors better understand your liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are either a healthy adult with a BMI between 18 and 25.5, or you have chronic liver disease (like hepatitis, fatty liver, or cirrhosis).
- You are not pregnant.
- You can drink a thin liquid by mouth (the test involves drinking a small amount of a special liquid).
- If you have cirrhosis, you have not been in the hospital in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how fast your body breaks down albumin, a protein made by the liver, using a safe tracer called a stable isotope. It compares healthy people with those who have liver cirrhosis to better understand liver function.
This study tests a new blood test (HepQuant DuO) to see how well it measures liver function in people with alcohol-related liver disease. If you have liver damage from alcohol and either a recent serious liver flare-up or also a fatty liver condition (NASH), this study may help your doctors understand your liver better.
This study tests new blood tests and MRI scans to see how well your liver works during radiation therapy for liver cancer. It may help doctors better plan treatment and monitor your liver health.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This research study evaluates people with liver disease or at risk for liver disease, and compares them with healthy volunteers. The goal is to better understand liver disease and improve how doctors diagnose and treat it.
This trial looks at tiny particles in the blood (extracellular vesicles) to see if they can help doctors understand and track liver disease. It includes healthy volunteers, people with diabetes and liver scarring, and people with cirrhosis, with the goal of finding better biomarkers.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.